Haleon UK Holdings (No.3) Limited

Active13401293 Private limited company
Incorporated
16 May 2021 (5 years)
Previously known as
GSK Consumer Healthcare Holdings (No.3) Limited (until 18 August 2023)
This list may be incomplete. See all names on Companies House
Industry
Activities of other holding companies n.e.c. (64209)
Accounts type
Audit exemption subsidiary
Region
South East
Address
Building 5
First Floor
The Heights
Weybridge
KT13 0NY

Filing status

Accounts due
30 September 2027
Last accounts
31 December 2025
Conf. stmt due
22 May 2027
Last conf. stmt
8 May 2026

Officers 3 active

Officer details are public data from the Companies House register.

Officer history (5 former)
20 September 2024
Resigned Whittle, Thomas as Director
11 May 2023
Appointed Whittle, Thomas as Director
14 April 2023
Resigned Senior, David Christopher as Director
6 April 2022
Appointed Haleon UK Corporate Secretary Limited as Corporate Director
6 April 2022
Appointed Haleon UK Corporate Director Limited as Corporate Director
6 April 2022
Resigned Edinburgh Pharmaceutical Industries Limited as Corporate Director
6 April 2022
Resigned The Wellcome Foundation Limited as Corporate Director
4 March 2022
Appointed El Ansari, Khalid as Director
4 March 2022
Appointed Senior, David Christopher as Director
4 March 2022
Resigned Sadler, John Michael as Director
16 May 2021
Appointed Sadler, John Michael as Director
16 May 2021
Appointed Edinburgh Pharmaceutical Industries Limited as Corporate Director
16 May 2021
Appointed The Wellcome Foundation Limited as Corporate Director

Ownership 1 active

People and entities with significant control, from the Companies House PSC register

Corporate entity · Notified 14 July 2022
Owns 75–100% of shares
Holds 75–100% of voting rights
Right to appoint and remove directors
Private Limited Company
Reg. no. 08998608

Holdings 4

Companies where Haleon UK Holdings (No.3) Limited is registered as a person with significant control

Owns 75–100% of shares
Active
Owns 75–100% of shares
Active
Owns 75–100% of shares
Active
Owns 75–100% of shares
Active
Former controllers (6)
14 July 2022
Ceased Glaxosmithkline Consumer Healthcare Holdings (No.2) Limited — Owns 75–100% of shares
22 November 2021
Ceased GSK Consumer Healthcare Holdings (No.7) Limited — Owns 75–100% of shares
22 November 2021
Ceased Consumer Healthcare Intermediate Holdings Limited — Owns 25–50% of shares
22 November 2021
Ceased Consumer Healthcare Holdings Limited — Owns 75–100% of shares
22 November 2021
Ceased GSK Consumer Healthcare Holdings (No.5) Limited — Owns 75–100% of shares
28 June 2021
Ceased Prism PCH Limited — Owns 75–100% of shares

Group structure 6 shown

Ownership group derived from the Companies House PSC register

Haleon Intermediate Holdings Limited Owns 75–100% of shares
Haleon UK Holdings (No.2) Limited Holds 25–50% of voting rights
Consumer Healthcare Holdings Limited Owns 75–100% of shares
Haleon UK Holdings Limited Owns 75–100% of shares
Haleon UK Holdings (No.3) Limited This company Owns 75–100% of shares

Filings

Recent filings only. See the full history on Companies House

DateDescriptionMade Up ToPagesPDF
4 November 2026Other filing
4 November 2026Audit exemption subsidiary accounts31 December 2025
23 October 2026Other filing
23 October 2026Accounts filing

Some other companies at this address

Other companies in this industry

Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →

← Back to companies Official record on Companies House ↗

Already have an account?

Create your account

Save searches and get the weekly email of new matches.

First name is required.
Last name is required.
Enter an email address like name@example.com.
Must be at least 8 characters. Password must be at least 8 characters.

Already have an account?